Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 9, 2005, Pages 3435-3440

  Rekasi, Zoltan ^a,b   Czompoly, Tamas ^a   Schally, Andrew V ^c,d   Boldizsar, Ferenc ^a   Varga, Jozsef L ^c,d   Zarandi, Marta ^e   Berki, Timea ^a   Horvath, Reka A ^a,b   Nemeth, Peter ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Calcium; Cancer therapy; Growth hormone releasing hormone antagonist; Growth hormone releasing hormone receptor

Indexed keywords

EDETIC ACID; GROWTH HORMONE RELEASING FACTOR[1-29]; HORMONE INHIBITOR; JV 138; NIFEDIPINE; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXTRACELLULAR CALCIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

APOPTOSIS; CALCIUM; CELL LINE, TUMOR; EDETIC ACID; FLOW CYTOMETRY; GROWTH HORMONE-RELEASING HORMONE; HUMANS; MALE; NIFEDIPINE; PHOSPHATIDYLSERINES; PROSTATIC NEOPLASMS;

EID: 14744277399     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0410006102     Document Type: Article

References (49)

1. Schally, A. V. & Varga, J. L. (1999) Trends Endocrinol. Metabol. 10, 383-391.
2. Schally, A. V., Comaru-Schally, A. M., Plonowski, A., Nagy, A., Halmos, G. & Rekasi, Z. (2000) Prostate 45, 158-166.
3. Schally, A. V., Comaru-Schally, A. M., Nagy, A., Kovacs, M., Szepeshazi, K., Plonowski, A., Varga, J. L. & Halmos, G. (2001) Front. Neuroendocrinol. 22, 248-291.
4. Frohman, L. A. & Kineman, R. D. (2002) Trends Endocrinol. Metab. 13, 299-303.
5. Schally, A. V. & Comaru-Schally, A. M. (2003) in Cancer Medicine, eds. Kufe, D. W., Pollock, R. E., Weichselbaum, R. R., Bast, R. C., Jr., Gansler, T. S., Holland, J. F. & Frei, E., III (BC Decker, Hamilton, ON, Canada), 6th Ed., pp. 911-926.
6. Schally, A. V., Szepeshazi, K., Nagy, A., Comaru-Schally, A. M. & Halmos, G. (2004) Cell. Mol. Life Sci. 61, 1042-1068.
7. Furstenberger, G. & Senn, H. J. (2002) Lancet Oncol. 3, 298-302.
8. Kiaris, H., Schally, A. V., Varga, J. L., Groot, K. & Armatis, P. (1999) Proc. Natl. Acad. Sci. USA 96, 14894-14898.
9. Kahan, Z., Varga, J. L., Schally, A. V., Rekasi, Z., Armatis, P., Chatzistamou, I., Czompoly, T. & Halmos, G. (2000) Breast Cancer Res. Treat. 60, 71-79.
10. Chatzistamou, I., Schally, A. V., Varga, J. L., Groot, K., Busto, R., Armatis, P. & Halmos, G. (2001) Anticancer Drugs 12, 761-768.
11. Chatzistamou, I., Schally, A. V., Varga, J. L., Groot, K., Armatis, P., Busto, R. & Halmos, G. (2001) J. Clin. Endocrinol. Metab. 86, 2144-2152.
12. Braczkowski, R., Schally, A. V., Plonowski, A., Varga, J. L., Groot, K., Krupa, M. & Armatis, P. (2002) Cancer 95, 1735-1745.
13. Busto, R., Schally, A. V., Varga, J. L., Garcia-Fernandez, M. O., Groot, K., Armatis, P. & Szepeshazi, K. (2002) Proc. Natl. Acad. Sci. USA 99, 11866-11871.
14. Zeitler, P. & Siriwardana, G. (2002) Endocrine 18, 85-90.
15. Kiaris, H., Koutsilieris, M., Kalofoutis, A. & Schally, A. V. (2003) Expert Opin. Investig. Drugs 12, 1385-1394.
16. Mayo, K. E. (1992) Mol. Endocrinol. 6, 1734-1744.
17. Gaylinn, B. D., Harrison, J. K., Zysk, J. R., Lyons, C. E., Lynch, K. R. & Thorner, M. O. (1993) Mol. Endocrinol. 7, 77-84.
18. Matsubara, S., Sato, M., Mizobuchi, M., Niimi, M. & Takahara, J. (1995) Endocrinology 136, 4147-4150.
19. Mayo, K. E., Miller, T. L., De Almeida, V., Zheng, J. & Godfrey, P. A. (1996) Ann. N.Y. Acad. Sci. 805, 184-203.
20. Boisvert, C., Pare, C., Veyrat-Durebex, C., Robert, A., Dubuisson, S., Morel, G. & Gaudreau, P. (2002) Endocrinology 143, 1475-1484.
21. Boulanger, L., Girard, N., Strecko, J. & Gaudreau, P. (2002) Peptides 23, 1187-1194.
22. Rekasi, Z., Varga, J. L., Schally, A. V., Halmos, G., Armatis, P., Groot, K. & Czompoly, T. (2000) Endocrinology 141, 2120-2128.
23. Maruno, K., Absood, A. & Said, S. I. (1998) Proc. Natl. Acad. Sci. USA 95, 14373-14378.
24. Sherwood, N. M., Krueckl, S. L. & McRory, J. E. (2000) Endocr. Rev. 21, 619-670.
25. Halmos, G., Schally, A. V., Varga, J. L., Plonowski, A., Rekasi, Z. & Czompoly, T. (2000) Proc. Natl. Acad. Sci. USA 97, 10555-10560.
26. Rekasi, Z., Czompoly, T., Schally, A. V. & Halmos, G. (2000) Proc. Natl. Acad. Sci. USA 97, 10561-10566.
27. Chopin, L. K. & Herington, A. C. (2001) Prostate 49, 116-121.
28. Busto, R., Schally, A. V., Braczkowski, R., Plonowski, A., Krupa, M., Groot, K., Armatis, P. & Varga, J. L. (2002) Regul. Peptides 108, 47-53.
29. Halmos, G., Schally, A. V., Czompoly, T., Krupa, M., Varga, J. L. & Rekasi, Z. (2002) J. Clin. Endocrinol. Metab. 87, 4707-4714.
30. Plonowski, A., Schally, A. V., Busto, R., Krupa, M., Varga, J. L. & Halmos, G. (2002) Peptides 23, 1127-1133.
31. Plonowski, A., Schally, A. V., Letsch, M., Krupa, M., Hebert, F., Busto, R., Groot, K. & Varga, J. L. (2002) Prostate 52, 173-182.
32. Kiaris, H., Schally, A. V., Busto, R., Halmos, G., Artavanis-Tsakonas, S. & Varga, J. L. (2002) Proc. Natl. Acad. Sci. USA 99, 196-200.
33. Chatzistamou, I., Schally, A. V., Kiaris, H., Politi, E., Varga, J., Kanellis, G., Kalofoutis, A., Pafiti, A. & Koutselini, H. (2004) Eur. J. Endocrinol. 151, 391-396.
34. Toller, G. L., Horvath, J. E., Schally, A. V., Halmos, G., Varga, J. L., Groot, K., Chism, D. & Zarandi, M. (2004) Proc. Natl. Acad. Sci. USA 101, 15160-15165.
35. Rekasi, Z., Varga, J. L., Schally, A. V., Plonowski, A., Halmos, G., Csernus, B., Armatis, P. & Groot, K. (2001) Peptides 22, 879-886.
36. Garcia-Fernandez, M. O., Schally, A. V., Varga, J. L., Groot, K. & Busto, R. (2003) Breast Cancer Res. Treat. 77, 15-26.
37. Kanashiro, C. A., Schally, A. V., Zarandi, M., Hammann, B. D. & Varga, J. L. (2004) Int. J. Cancer 112, 570-576.
38. Hawkins, T. E., Das, D., Young, B. & Moss, S. E. (2002) Proc. Natl. Acad. Sci. USA 99, 8054-8059.
39. Brazeau, P., Ling, N., Esch, F., Bohlen, P., Mougin, C. & Guillemin, R. (1982) Biochem. Biophys. Res. Commun. 109, 588-594.
40. Lussier, B. T., French, B. M., Moor, B. C. & Kraicer, J. (1991) Endocrinology 128, 592-603.
41. Varga, J. L., Schally, A. V., Csernus, V. J., Zarandi, M., Halmos, G., Groot, K. & Rekasi, Z. (1999) Proc. Natl. Acad. Sci. USA 96, 692-697.
42. Coy, D. H., Vilchez-Martinez, J. A., Coy, E. J. & Schally, A. V. (1976) J. Med. Chem. 19, 423-425.
43. Bajusz, S., Kovacs, M., Gazdag, M., Bokser, L., Karashima, T., Csernus, V. J., Janaky, T., Guoth, M. & Schally, A. V. (1988) Proc. Natl. Acad. Sci. USA 85, 1637-1641.
44. Minta, A., Kao, J. P. & Tsien, R. Y. (1989) J. Biol. Chem. 264, 8171-8178.
45. Boldizsar, F., Berki, T., Miseta, A. & Nemeth, P. (2002) Immunol. Lett. 82, 159-164.
46. Vermes, I., Haanen, C., Steffens-Nakken, H. & Reutelingsperger, C. (1995) J. Immunol. Methods 184, 39-51.
47. Zarandi, M., Horvath, J. E., Halmos, G., Pinski, J., Nagy, A., Groot, K., Rekasi, Z. & Schally, A. V. (1994) Proc. Natl. Acad. Sci. USA 91, 12298-12302.
48. Kiaris, H., Chatzistamou, I., Schally, A. V., Halmos, G., Varga, J. L., Koutselini, H. & Kalofoutis, A. (2003) Proc. Natl. Acad. Sci. USA 100, 9512-9517.
49. Kineman, R. D. (2000) Proc. Natl. Acad. Sci. USA 97, 532-534.